SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | ADIAL PHARMACEUTICALS, INC. | 166,972 | 10.0% | EDGAR |
SC 13D/A | 2022-02-18 | Schuyler Kevin | ADIAL PHARMACEUTICALS, INC. | 1,106,277 | 4.6% | EDGAR |
SC 13G/A | 2022-02-14 | Peikin Mark Howard | ADIAL PHARMACEUTICALS, INC. | 904,444 | 4.4% | EDGAR |
SC 13G/A | 2021-08-18 | Peikin Mark Howard | ADIAL PHARMACEUTICALS, INC. | 1,346,741 | 6.7% | EDGAR |
SC 13D/A | 2021-08-13 | Stilley William B. III | ADIAL PHARMACEUTICALS, INC. | 2,005,752 | 9.4% | EDGAR |
SC 13G | 2021-08-13 | Peikin Mark Howard | ADIAL PHARMACEUTICALS, INC. | 1,120,241 | 5.5% | EDGAR |
SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | ADIAL PHARMACEUTICALS, INC. | 712,500 | 4.5% | EDGAR |
SC 13D/A | 2021-02-08 | Stilley William B. III | ADIAL PHARMACEUTICALS, INC. | 1,769,363 | 11.1% | EDGAR |
SC 13D/A | 2020-12-11 | Stilley William B. III | ADIAL PHARMACEUTICALS, INC. | 1,513,310 | 10.0% | EDGAR |
SC 13G | 2020-06-19 | ARMISTICE CAPITAL, LLC | ADIAL PHARMACEUTICALS, INC. | 712,500 | 5.0% | EDGAR |
SC 13G | 2020-06-18 | INTRACOASTAL CAPITAL, LLC | ADIAL PHARMACEUTICALS, INC. | 470,000 | 3.4% | EDGAR |
SC 13G/A | 2020-01-21 | Empery Asset Management, LP | ADIAL PHARMACEUTICALS, INC. | 676,126 | 5.0% | EDGAR |
SC 13D/A | 2019-04-01 | Johnson Bankole A. | ADIAL PHARMACEUTICALS, INC. | 1,599,174 | 15.4% | EDGAR |
SC 13D/A | 2019-03-29 | Stilley William B. III | ADIAL PHARMACEUTICALS, INC. | 982,292 | 9.4% | EDGAR |
SC 13G | 2019-03-01 | Empery Asset Management, LP | ADIAL PHARMACEUTICALS, INC. | 816,051 | 8.4% | EDGAR |
SC 13D | 2018-11-14 | Johnson Bankole A. | ADIAL PHARMACEUTICALS, INC. | 1,511,485 | 22.3% | EDGAR |
SC 13D | 2018-11-14 | Newman James W. Jr. | ADIAL PHARMACEUTICALS, INC. | 683,064 | 9.8% | EDGAR |
SC 13D | 2018-11-14 | Schuyler Kevin | ADIAL PHARMACEUTICALS, INC. | 1,446,477 | 19.2% | EDGAR |
SC 13D | 2018-11-14 | Stilley William B. III | ADIAL PHARMACEUTICALS, INC. | 934,239 | 13.6% | EDGAR |